Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Article English OPEN
Marjan W Attaei, MA; Rasha Khatib, PhD; Prof Martin McKee, DSc; Prof Scott Lear, PhD; Prof Gilles Dagenais, MD; Ehimario U Igumbor, PhD; Khalid F AlHabib, MD; Prof Manmeet Kaur, PhD; Lanthe Kruger, PhD; Prof Koon Teo, PhD; Fernando Lanas, MD; Khalid Yusoff, MD; Aytekin Oguz, MD; Prof Rajeev Gupta, PhD; Afzalhussein M Yusufali, MD; Ahmad Bahonar, MD; Prof Raman Kutty, MD; Prof Annika Rosengren, MD; Prof Viswanathan Mohan, DSc; Prof Alvaro Avezum, PhD; Prof Rita Yusuf, PhD; Prof Andrzej Szuba, PhD; Sumathy Rangarajan, MSc; Clara Chow, PhD; Prof Salim Yusuf, DPhil; S Yusuf; S Rangarajan; K K Teo; C K Chow; M O'Donnell; ... view all 432 authors

Background: Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medici... View more
Share - Bookmark